Bio Bulletin Q3 2026 banner

Q3 2026 · July to September

From the CEO

A message from Lauren

Lauren Ledwell

“We’ve built a strong platform in PEI. Now it’s about turning that strength into continued growth, investment and opportunity.”

It’s been a busy and exciting quarter in the PEI bioscience sector and there is equally a lot to be excited about as we look ahead.

Our team over the past few months has spent time with companies across the cluster, investors and partners, and government leaders, both here at home and nationally. With growing national focus on life sciences commercialization, sovereign capabilities and health security, there is a real opportunity for PEI’s bioscience sector to play an even greater role in what comes next.

We’re seeing this momentum come to life across the cluster. Companies are growing and entering new markets through M&A, new marquee customers, and strategic partnerships. There are major infrastructure projects underway. New opportunities are also emerging in areas from AI to advanced manufacturing and in health security, defence, and dual-use technologies. This quarter, our AI Readiness Survey helped identify where companies are already putting AI to work and where we can help accelerate adoption. We also brought PEI’s bioscience capabilities to the Province’s Defence Strategy Expert Panel, making the case for the role our cluster can play in Canada’s growing focus on health security and defence (more below).

At the BioAlliance, our focus is on helping turn this momentum into continued growth - helping companies access the capital, talent, infrastructure and markets they need to scale; attracting new investment and capabilities to PEI; and making sure our sector has a strong voice in the policy and investment conversations happening nationally.

We’re seeing positive movement on that front as well. The federal government’s new Productivity Mega Deduction is the kind of policy shift that can make a real difference in making Canada a more competitive place to invest, build and grow. Capital was also a recurring theme in conversations around the Canada Investment Summit this quarter: we need more growth capital at the table for investment-ready projects and companies, alongside policy that helps de-risk investment and enables companies to scale here at home. We’ll continue pushing on both fronts - including new approaches to strengthening R&D investment and attracting the right mix of growth capital to enable scale.

We're also getting ready to share the next chapter for the BioAlliance. Over the past several months, we've been working with our Board, companies and partners on a refreshed strategy for the cluster - one that builds on a very strong foundation while being clear about where we believe PEI can compete and lead over the next five years. Stay tuned for more to come this Fall.

Please subscribe to our mailing list and follow us on LinkedIn so you don't miss out.

In the meantime, thank you to the companies, researchers, partners and people who continue to build this sector. There is real momentum here, and we are all very excited about moving forward!

With thanks,

Lauren Ledwell

Chief Executive Officer, PEI BioAlliance

This quarter at the BioAlliance

Initiatives

BioAccelerator Advances

Construction of the 38,000 square foot facility has advanced significantly over the summer, with the building expected to be weather tight by mid-November. The competition for the new Facility Manager role is underway and we hope to share news of this new team member shortly. Designed to be adaptable to tenants' needs, the BioAccelerator is a key asset in our infrastructure strategy for the sector. Watch our LinkedIn page for progress updates.

View Video

PEI BioAlliance Releases AI Readiness Survey Report

This pulse check on AI adoption across the cluster illustrates that AI use is already widespread and that there is strong enthusiasm for experimentation. It also reports that more expertise is needed to realize AI's full potential, with clear opportunities around governance, data readiness, workforce capability, and implementation support.

Request the Report

Advocacy with Federal Leaders

Over the summer and early fall, cluster companies and the PEI BioAlliance team met with federal leaders to share the business realities and needs of PEI companies in the current economic climate. We advocated for access to capital, support to scale up, and immigration pathways for specialized talent. Engagements included the Minister of Finance as part of pre-budget consultations, the Minister of Industry, the Parliamentary Secretary to the Minister of Industry, members of the Standing Committee on Finance, Minister responsible for ACOA and local MPs Sean Casey, Kent MacDonald and Heath MacDonald. We are also looking for opportunities to engage on the upcoming Commercialization Strategy, a recommendation of the Pharmaceutical and Life Sciences Task Force report issued in July.

PEI's Defence Value Proposition

As part of the province's defence panel work, the PEI BioAlliance is developing a value proposition for bioscience in biosecurity and biomedical countermeasures. Biodefence is prioritized as a sovereign capability in Canada's Defence Industrial Strategy (DIS) where we believe our sector can have impact. The defence panel met at our office on Sept. 8 and had several presentations from companies in the sector. Discovery is now underway, drawing on PEI's research and innovation strengths, including dual-use capabilities, to build a roadmap and opportunities list. The BioAlliance team will be at DEFSEC Atlantic 2026. Are you considering defence applications? Reach out.

Email Eric Cook

Out and about

Sector Highlights

Telling Our Story to National Leaders 1

Telling Our Story to National Leaders

July 2026

The PEI BioAlliance team and companies representing our sector participated at several events that PEI hosted as our country's leaders were in the province for the Council of the Federation. It provided the opportunity to meet Prime Minister Carney and the Premiers for meaningful exchange and the opportunity to share the story behind our thriving bioscience sector.

RPS Biologiques Facility Tour 1

RPS Biologiques Facility Tour

July 2026

The PEI BioAlliance toured the production facility of RPS Biologiques Inc with Dr. Subrata Chowdhury and Ranjana Banerjee. The company is at a milestone on a journey of years of research and product development to manufacture high quality, biologically based products that support fish and animal health while reducing the need for traditional chemical inputs.

Summer Social 1

Summer Social

July 2026

Members gathered for the season's top bioscience networking event, bringing companies, researchers and partners together across the cluster. Thank you again to our generous sponsors VWR / Avantor who were represented (left to right) by Chris Mulholland, Diane Roy, and Bruno Cuoci.

Natural Products Canada funding announcement 1

Natural Products Canada funding announcement

July 2026

Natural Products Canada received a $50 million boost from the Government of Canada, augmenting its $94.8 million initiative supporting small and medium sized innovators.

New Members Join the PEI BioAlliance Board of Directors 1

New Members Join the PEI BioAlliance Board of Directors

July 2026

The Prince Edward Island BioAlliance Board of Directors announced the appointment of Katherine O'Halloran and Natalie Mitton to its Board of Directors.

Roundtable with Federal Leaders 1

Roundtable with Federal Leaders

Summer 2026

Industry leaders and the PEI BioAlliance team met around the table with federal officials to share the business realities and needs of bioscience companies in the province.

CASTL Receives Federal Investment to Develop Bioscience Talent 1

CASTL Receives Federal Investment to Develop Bioscience Talent

August 2026

The Government of Canada will invest $8.7 million in CASTL through the Sectoral Workforce Solutions Program. It will help CASTL address critical skills shortages, connect qualified workers with employers and strengthen Canada's capacity to produce life-saving drugs, vaccines and health products here at home.

CASTL and PEI BioAlliance: A Highlight of the Atlantic Economic Panel Report 1

CASTL and PEI BioAlliance: A Highlight of the Atlantic Economic Panel Report

September 2026

Lauren Ledwell, CEO of PEI BioAlliance, and Penny Walsh, CEO of CASTL, joined Minister Sean Fraser and the distinguished business leaders of our region at the release of the Panel's report. Bolder Ambitions names PEI BioAlliance's life sciences cluster as a model of innovation-driven export growth, and highlights CASTL's biomanufacturing training as a workforce success: 1,500+ trained, 350 reskilled, 50+ partners.

BioPort 2026 1

BioPort 2026

September 2026

At BioPort's 25th anniversary, PEI helped show why life sciences matters. Joanna Beattie, Program Manager, represented Emergence at the booth, Lauren Ledwell, CEO, hosted the Day 1 afternoon program, Sidney Reid, COO of CASTL, spoke on the talent panel, and Jason Cleaversmith, Executive Director of Emergence, contributed as part of the conference planning committee. Thank you to Life Sciences Nova Scotia for putting on an excellent event on crucial topics for our industry in this region.

Company Spotlight

Tunistrong Technologies Inc.

Matt Dunlop with a tunicate harvest collected from mussel lines.
Matt Dunlop with a tunicate harvest collected from mussel lines.

From Lab to Market: A UPEI Researcher Takes the Commercialization Path

Matt Dunlop · Founder and CEO, Tunistrong Technologies Inc.

Matt Dunlop started out studying waste valorization as a graduate student at UPEI. Today, he is CEO of Tunistrong Technologies Inc., a Charlottetown-based biotech company turning invasive tunicates, a major nuisance for the region's mussel farms, into high-performance biomaterials.

From Thesis to Company

During his graduate research, Dunlop learned that tunicates produce the world's only animal-derived cellulose. That finding became the foundation of his work: developing a process to extract proteins and nanocellulose from tunicates for practical use. Rather than leaving the discovery in the lab, Dunlop chose to build a company around it.

The result is “Nature's Rebar,” a cellulose nanomaterial that can be sold to manufacturers as an additive to improve products like concrete and adhesives. Nanocellulose particles have a tensile strength about 8x stronger than steel, with a significantly reduced environmental footprint.

“It's a real-world demonstration of ways to create value (from waste), circular economy thinking and sustainability, in a very clear-cut manner,” says Dunlop.

Take note

Save the Date

Funding

BioAlliance Events

Trade and Conference Events

Learning & Development